Major Growth Driving Factors:

The growing target patient population, ongoing product development, and commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across the emerging markets, growth in market demand for effective neurovascular devices, increase in research in the field of neurovascular therapies, rise in demand for minimally invasive neurosurgical procedures, and increase in awareness among neurosurgeons about minimally invasive surgical procedures are high growth prospects for the neurovascular devices market during the forecast period.

Market Estimation Methodology:

# The key players in the industry and demand have been identified through extensive secondary research, and their market share has been determined through both primary and secondary research.

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

# All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

# The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Expected Revenue Growth:

The neurovascular devices market size is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion by 2026, at a CAGR of 8.6%.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847

The aneurysm coiling & embolization devices segment is expected account for the largest share of the neurovascular devices market during the forecast period.

On the basis of product, the neurovascular devices market is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neuro thrombectomy devices. The aneurysm coiling & embolization devices product segment, by type, is further segmented into embolic coils, flow diversion devices, and liquid embolic agents.

The aneurysm coiling & embolization devices segment is estimated to account for the largest share of the interventional neurology market, by product, in 2021, owing to growing end-user preference for minimally invasive neurosurgical procedures and increasing market availability of embolic coils for neurovascular treatment.

End Users:

The ambulatory care centers segment is expected to grow at the highest CAGR during the forecast period.

Based on end-user, the neurovascular devices market has been segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories, and academic institutes. As of 2020, hospitals & surgical centers are estimated to account for the largest share of the global interventional neurology market in 2021, while ambulatory care centers are projected to register the highest CAGR during the forecast period.

Growing patient preference for minimally invasive medical procedures, rising number of ambulatory surgery centers across developed countries, along with the ease of scheduling, the focused clinical staff, the improved productivity, and the increased safety, and efficacy of these centers, are the major factors that are expected to drive the growth of this end-user segment in the coming years.

North America is expected to be the largest market during the forecast period.

North America is estimated to be the largest market for interventional neurology during the forecast period. The neurovascular devices market in North America is driven primarily by factors such as the growing target patient population for neurovascular diseases, rising awareness among neurosurgeons regarding the benefits offered by interventional neurology devices, and ongoing government initiatives to modernize & expand healthcare infrastructure. Additionally, the adoption of these devices has increased due to falling product prices, thereby further supporting the market growth in this region.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=847

Recent Developments in the Global Interventional Neurology Market:

# In 2020, Johnson & Johnson launched Cerenovus Stroke Solutions, which includes a suite of three devices designed to aid physicians in clot removal procedures. The devices include the Cerenovus Large Bore Catheter, Cerebase DA Guide Sheath, and Embotrap III Revascularization Device.

# In 2021, Penumbra partnered with Genesis MedTech to expand the neurovascular market in China.

# In 2021, Pehnox established a new entity in the UK in light of Brexit to strengthen its footprint in the key markets across Europe.

Read More About the Related Topics:

Neuromodulation Market - Future Forecasts to 2027

Peripheral Vascular Devices Market - Future Forecasts to 2026

Interventional Cardiology Devices Market - Future Forecasts to 2025